Salutaris Medical Devices
Stage
Series D | AliveTotal Raised
$10.82MAbout Salutaris Medical Devices
Salutaris Medical Devices is a clinical stage medical device company focused on the ophthalmic sector. The company's main product is a patented, FDA-cleared device called BetaCurve, designed to treat various eye diseases, including advanced age-related macular degeneration, using precision beta radiotherapy. The device is used in a quick, outpatient procedure that requires only one treatment, offering a potential alternative for patients who do not respond well to standard treatments. It is based in Tucson, Arizona.
Loading...
Loading...
Salutaris Medical Devices Patents
Salutaris Medical Devices has filed 23 patents.
The 3 most popular patent topics include:
- diseases of the eye and adnexa
- disorders of sclera and cornea
- dosage forms
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/15/2018 | 12/1/2020 | Radiation therapy, Diseases of the eye and adnexa, Disorders of sclera and cornea, Medical physics, Ophthalmology | Grant |
Application Date | 1/15/2018 |
|---|---|
Grant Date | 12/1/2020 |
Title | |
Related Topics | Radiation therapy, Diseases of the eye and adnexa, Disorders of sclera and cornea, Medical physics, Ophthalmology |
Status | Grant |
Latest Salutaris Medical Devices News
Dec 20, 2016
Thumbnail December 20, 2016 12:02 AM Eastern Standard Time TUCSON, Ariz.--( BUSINESS WIRE )--Salutaris Medical Devices, Inc. (SalutarisMD®) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their SMD-Sr90-DA™ Radionuclide Brachytherapy Source (RBS). The SMD-Sr90-DA™ RBS device is indicated for episcleral brachytherapy. The device is intended for use within a manual brachytherapy applicator system. Dr. Laurence Marsteller, CEO of SalutarisMD, commented, "The SalutarisMD team is quite proud and excited to have reached this important regulatory and commercial milestone. It further validates our company's progress, and advances its clinical research agenda. " SalutarisMD is developing a minimally invasive procedure that can be performed in an outpatient setting in approximately 15 minutes. The patented and patent pending technology delivers a single-use brachytherapy procedure. SalutarisMD's technology is being engineered to deliver improved outcomes for wet AMD. Caution: Investigational Device About SalutarisMD SalutarisMD® (Salutaris Medical Devices, Inc. and Salutaris Medical Devices, Ltd.) is a pre-revenue medical device company founded to develop an investigational ophthalmic treatment for wet age-related macular degeneration (wet AMD). HOYA Group announced in March 2015 that it had closed an investment financing in SalutarisMD to further SalutarisMD's growth strategy. For more information visit www.SalutarisMD.com or www.SalutarisMD.co.uk . Salutaris Medical Devices, Inc. 4340 N. Campbell Ave. Suite 266 Tucson, AZ 85718
Salutaris Medical Devices Frequently Asked Questions (FAQ)
Where is Salutaris Medical Devices's headquarters?
Salutaris Medical Devices's headquarters is located at 4330 N Campbell Ave, Tucson.
What is Salutaris Medical Devices's latest funding round?
Salutaris Medical Devices's latest funding round is Series D.
How much did Salutaris Medical Devices raise?
Salutaris Medical Devices raised a total of $10.82M.
Who are the investors of Salutaris Medical Devices?
Investors of Salutaris Medical Devices include Desert Angels, Translational Accelerator and Tucson Desert Angels.
Who are Salutaris Medical Devices's competitors?
Competitors of Salutaris Medical Devices include Relievant Medsystems, Wright Medical Group, SteadyMed Therapeutics, DFine, Spinal Modulation and 7 more.
Loading...
Compare Salutaris Medical Devices to Competitors
BioWave is a company that focuses on the development of non-opioid, patented pain blocking technology in the healthcare industry. The company's main offerings include wearable devices that deliver high-frequency neurostimulation to pain nerves, inhibiting the propagation of action potential along the nerve and blocking the transmission of pain signals to the brain. This technology is primarily used in the sports medicine and chronic pain management sectors. It was founded in 1997 and is based in Norwalk, Connecticut.
AllTranz aims to provide relief from chronic pain to patients outside the hospital setting.
Trigemina is focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products. Trigemina's lead product candidate, TI-001, is a patented new application of oxytocin. TI-001 has shown promising results for use as a safe and effective therapy for all forms of chronic and subacute head pain.
MetaCure is a clinical-stage device company focused on the treatment of adult type II diabetes via an implantable pulse generator delivering electrical stimulation via gastric contractility modulation.
Biomimedica is developing earlier intervention solutions to treat osteoarthritis that will allow patients to maintain a pain-free, active lifestyle.
Spineworks Medical, Inc. designs and manufactures medical devices for spinal surgery.
Loading...